Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Cardiac Monitoring Market

  • MAR2978997
  • 206 Pages
  • May 2018
  • Pharmaceuticals
Download Sample    Get Discount   
 
The Global Cardiac Monitoring Market was valued at US$ XX Mn in 2016 and is expected to reach US$ XX Mn by 2022 with an estimated CAGR growth of XX% during the forecasted period. Cardiac arrests are a norm of the present. Cardiac Monitoring refers to the process of tracking and detecting these disorders so that measures might be taken to avoid the incidence of the sudden attacks.

The market is predicted to witness an extended increase in attention and growth rate thanks to the rise in number of cardiac diseases detected and the awareness of the same by various health sector organizations.

Market Dynamics

Cardiac arrests are one of the major causes of deaths in the developed countries. The reasons for the cardiac arrests are unhealthy lifestyles led by people. This in turn has led to people trying to finds ways to monitor and avoid the occurrence of these kind of disorders. This consequently has led to an increase in interest for the cardiac monitoring market. The future looks good for the industry taking into account the increasing cases of cardiac diseases which show no indications of slowing down any time in the future.

Market Segmentation

The market can be segmented based on the product type, the place of application and the end user. Based on the product type, the cardiac monitoring market can be divided into ECG devices, the cardiac output monitoring devices, etc. The cardiac rhythm management devices can be further divided into the defibrillators, pacemakers, etc. The ECG devices hold the biggest market share. The end user division involves classifying under the headers of ambulatory care, research institutes, etc.

Regional/Geographic Analysis

In North America, Cardiac arrests are one of the major causes of deaths. The major players in the market are housed out of this region. Europe has the second biggest Cardiac devices market. Many firms in Germany, Switzerland and the Netherlands make viable devices for the general population. Asia is still coming to terms with the rise in demand and occurrence of the disorders and defects.

Opportunities

There has been an increase in the number of cardiac related problems and this has led to an increase in demand for the tracking and monitoring devices. The major players in this market are few and there are spaces for newer players to come. With an increase in demand and lack of supplies to meet the rise in demand, this market offers opportunities for newer players to take root and develop.

Key Players

The major players in this market are GE Healthcare, Philips Healthcare, Cardiac Science Corporation (U.S.) and Schiller AG.

--> Cardiac Monitoring Market Drivers, Restraints and Opportunities

--> Cardiac Monitoring Market Size & Forecast 2016 to 2022

--> Supply & Demand Value Chain

--> Cardiac Monitoring Market Current Trends

--> Competition & Major Companies

--> Technology and R&D Status

--> Porters Five Force Analysis

--> Strategic and Critical Success Factor Analysis of Key Players

Regional analysis for Cardiac Monitoring Market includes

--> North America

>> US and Canada

--> Latin America

>> Mexico, Brazil, Argentina and Rest of Latin America

--> Western Europe

>> EU5 (Germany, France, Italy, Spain, U.K.)

>> Nordic Countries (Denmark, Finland, Norway, and Sweden)

>> Benelux (Belgium, The Netherlands, and Luxembourg)

>> Rest of Western Europe

--> Eastern Europe

>> Russia

>> Poland

>> Rest of Eastern Europe

--> Asia Pacific

>> China

>> India

>> Japan

>> Australia and New Zealand

>> Rest of Asia Pacific

--> Middle East and Africa

>> GCC countries (Saudi Arabia, Oman, Qatar, Bahrain, UAE and Kuwait)

>> South Africa

>> North Africa

>> Rest of Middle East and Africa

This report is an elaborate aggregation of primary inputs from industry experts and participants across the supply chain. It provides in-depth market segmentation that is derived from extensive product mapping exercises, macro-economic factors and other qualitative and quantitative insights. The impact of all such factors are delivered across multiple market segments and geographies.

Report Highlights::

--> Detailed Historical Overview (Market Origins, Product Launch Timeline, etc.)

--> Consumer and Pricing Analysis

--> Market dynamics of the industry

--> In-depth Market Segmentation

--> Historical and Projected Market Sizing in terms of volume and value

--> Recent market trends and Impact Factors

--> R&D Status and Technology Overview

--> Extensive Industry Structure Coverage

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390